Harbor Capital Advisors Inc. Sells 16,088 Shares of Cabot Corporation $CBT

Harbor Capital Advisors Inc. lessened its stake in shares of Cabot Corporation (NYSE:CBT) by 42.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 22,153 shares of the specialty chemicals company’s stock after selling 16,088 shares during the period. Harbor Capital Advisors Inc.’s holdings in Cabot were worth $1,685,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. American Century Companies Inc. increased its position in shares of Cabot by 11.1% during the 2nd quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock worth $124,855,000 after purchasing an additional 166,460 shares during the last quarter. Bank of America Corp DE increased its holdings in Cabot by 2.0% during the second quarter. Bank of America Corp DE now owns 1,620,440 shares of the specialty chemicals company’s stock worth $121,533,000 after buying an additional 31,947 shares during the last quarter. Geode Capital Management LLC raised its position in Cabot by 1.8% during the second quarter. Geode Capital Management LLC now owns 1,421,934 shares of the specialty chemicals company’s stock worth $106,656,000 after acquiring an additional 25,717 shares in the last quarter. Sei Investments Co. lifted its stake in Cabot by 3.8% in the second quarter. Sei Investments Co. now owns 985,580 shares of the specialty chemicals company’s stock valued at $73,923,000 after acquiring an additional 36,072 shares during the last quarter. Finally, AQR Capital Management LLC lifted its stake in Cabot by 123.0% in the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after acquiring an additional 478,702 shares during the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Price Performance

Cabot stock opened at $66.14 on Friday. The company has a market capitalization of $3.50 billion, a price-to-earnings ratio of 11.00, a PEG ratio of 3.46 and a beta of 0.90. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.50. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $93.24. The stock’s 50 day moving average is $65.23 and its 200-day moving average is $72.78.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.72 by ($0.02). Cabot had a net margin of 8.91% and a return on equity of 24.55%. The firm had revenue of $899.00 million during the quarter, compared to the consensus estimate of $967.02 million. During the same quarter last year, the firm earned $1.80 earnings per share. The business’s revenue for the quarter was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Equities research analysts expect that Cabot Corporation will post 7.57 EPS for the current year.

Cabot Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 12th. Investors of record on Friday, November 28th were paid a $0.45 dividend. The ex-dividend date was Friday, November 28th. This represents a $1.80 annualized dividend and a dividend yield of 2.7%. Cabot’s dividend payout ratio is 29.95%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CBT. Mizuho lifted their price target on Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a research report on Monday. UBS Group reduced their target price on Cabot from $82.00 to $65.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. JPMorgan Chase & Co. decreased their target price on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a report on Friday, November 28th. Finally, Zacks Research downgraded Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cabot has a consensus rating of “Reduce” and an average target price of $66.33.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.